{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:11:45Z","timestamp":1761487905283},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,8,20]],"date-time":"2007-08-20T00:00:00Z","timestamp":1187568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,8,20]],"date-time":"2007-08-20T00:00:00Z","timestamp":1187568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1007\/s15010-007-6337-z","type":"journal-article","created":{"date-parts":[[2007,8,20]],"date-time":"2007-08-20T12:37:09Z","timestamp":1187613429000},"page":"326-333","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Safety and Immunogenicity of Early Vaccination with Two Doses of Tetravalent Measles-Mumps-Rubella-Varicella (MMRV) Vaccine in Healthy Children from 9 Months of Age"],"prefix":"10.1007","volume":"35","author":[{"given":"P.","family":"Goh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. S.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. H.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Willems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,20]]},"reference":[{"key":"6337_CR1","first-page":"130","volume":"79","author":"World Health Organization","year":"2004","unstructured":"World Health Organization (2004) Measles vaccines. Wkly Epidemiol Rec 79:130\u2013142","journal-title":"Wkly Epidemiol Rec"},{"key":"6337_CR2","unstructured":"World Health Organization: Measles: mortality reduction and regional elimination. Strategic plan: 2001\u20132005. World Health Organization 2001 (available at: http:\/\/www.who.int\/vaccines-documents\/DocsPDF01\/www573.pdf ). Accessed 21 November 2006"},{"key":"6337_CR3","first-page":"65","volume":"80","author":"World Health Organization","year":"2005","unstructured":"World Health Organization (2005) Progress toward elimination of measles and prevention of congenital rubella infection \u2013 European Region, 1990\u20132004. Wkly Epidemiol Rec 80:65\u201376","journal-title":"Wkly Epidemiol Rec"},{"key":"6337_CR4","unstructured":"World Health Organization: Eliminating measles and rubella and preventing congenital rubella infection: WHO European Region strategic plan 2005\u20132010. World Health Organization 2005, updated reprint 2006 (available at: http:\/\/www.euro.who.int\/document\/E87772.pdf ). Accessed 21 November 2006"},{"key":"6337_CR5","first-page":"235","volume":"30","author":"Robert Koch Institute","year":"2006","unstructured":"Robert Koch Institute (2006) Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand: Juli 2006. Epidemiol Bull 30:235\u2013254","journal-title":"Epidemiol Bull"},{"key":"6337_CR6","unstructured":"Institut de Veille Sanitaire: Bulletin \u00e9pid\u00e9miologique hebdomadaire Calendrier vaccinal 2005 et autres avis du conseil sup\u00e9rieur d\u2019hygi\u00e8ne publique de France relatifs \u00e0 la vaccination. 2005; 29\u201330: 142"},{"key":"6337_CR7","unstructured":"Prince Leopold Institute of Tropical Medicine: Travelling with children and babies. 2006 (available at: http:\/\/www.itg.be\/itg\/Uploads\/MedServ\/echildren.pdf ). Accessed 21 November 2006"},{"key":"6337_CR8","unstructured":"Statens Serum Institut: Danish childhood vaccination programme: measles-mumps-rubella vaccination (MMR). (Available at: http:\/\/www.ssi.dk\/sw19336.asp ). Accessed 21 November 2006"},{"key":"6337_CR9","unstructured":"Department of Health (United Kingdom): Measles, mumps and rubella. In: Immunisation against infectious disease (Green Book). 2006 (available at: http:\/\/www.dh.gov.uk\/assetRoot\/04\/13\/79\/20\/04137920.pdf ). Accessed 21 November 2006"},{"key":"6337_CR10","first-page":"E060223","volume":"11","author":"T Georgakopoulou","year":"2006","unstructured":"Georgakopoulou T, Grylli C, Kalamara E, Katerelos P, Spala G, Panagiotopoulos T (2006) Current measles outbreak in Greece. Euro Surveill 11:E060223.2","journal-title":"Euro Surveill"},{"key":"6337_CR11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","volume":"23","author":"B Kuter","year":"2004","unstructured":"Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, Reisinger K, Kim LL, Lupinacci L, Hartzel J, Chan I, Study Group for Varivax (2004) Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J 23:132\u2013137","journal-title":"Pediatr Infect Dis J"},{"key":"6337_CR12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/01.inf.0000219484.55858.a2","volume":"25","author":"A Arvin","year":"2006","unstructured":"Arvin A, Gershon A (2006) Control of varicella. Why is a two-dose schedule necessary? Pediatr Infect Dis J 25:475\u2013476","journal-title":"Pediatr Infect Dis J"},{"key":"6337_CR13","doi-asserted-by":"crossref","first-page":"e1070","DOI":"10.1542\/peds.2005-2085","volume":"117","author":"AS Lopez","year":"2006","unstructured":"Lopez AS, Guris D, Zimmerman L, Gladden L, Moore T, Haselow DT, Loparev VN, Schmid DS, Jumaan AO, Snow SL (2006) One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?. Pediatrics 117:e1070\u2013e1077","journal-title":"Pediatrics"},{"key":"6337_CR14","unstructured":"Centers for Disease Control and Prevention: Advisory Committee on Immunization Practices (ACIP): provisional recommendations for the prevention of varicella. 2006 (available at: http:\/\/www.cdc.gov\/nip\/recs\/provisional_recs\/default.htm ). Accessed 21 November 2006"},{"key":"6337_CR15","first-page":"213","volume":"3","author":"AM Ross","year":"2000","unstructured":"Ross AM, Fleming DM (2000) Chickenpox increasingly affects preschool children. Commun Dis Public Health 3:213\u2013215","journal-title":"Commun Dis Public Health"},{"key":"6337_CR16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/jcp.55.2.154","volume":"55","author":"G Kudesia","year":"2002","unstructured":"Kudesia G, Partridge S, Farrington CP, Soltanpoor N (2002) Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy. J Clin Pathol 55:154\u2013155","journal-title":"J Clin Pathol"},{"key":"6337_CR17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jmv.10364","volume":"70","author":"PE Kilgore","year":"2003","unstructured":"Kilgore PE, Kruszon-Moran D, Seward JF, Jumaan A, Van Loon FP, Forghani B, McQuillan GM, Wharton M, Fehrs LJ, Cossen CK, Hadler SC (2003) Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol 70:111\u2013118","journal-title":"J Med Virol"},{"key":"6337_CR18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/01.inf.0000122606.88429.8f","volume":"23","author":"B Rentier","year":"2004","unstructured":"Rentier B, Gershon AA, the Members of the European Working Group on Varicella (EUROVAR) (2004) Consensus: varicella vaccination of healthy children \u2013 a challenge for Europe. Pediatr Infect Dis J 23:379\u2013389","journal-title":"Pediatr Infect Dis J"},{"key":"6337_CR19","first-page":"113","volume":"20","author":"B Stuck","year":"2002","unstructured":"Stuck B, Stehr K, Bock HL (2002) Concomitant administration of varicella vaccine with combined measles, mumps, and rubella vaccine in healthy children aged 12 to 24 months of age. Asian Pac J Allergy Immunol 20:113\u2013120","journal-title":"Asian Pac J Allergy Immunol"},{"key":"6337_CR20","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.2165\/00003495-200363190-00012","volume":"63","author":"K Wellington","year":"2003","unstructured":"Wellington K, Goa KL (2003) Measles, mumps, rubella vaccine (Priorix\u2122; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella. Drugs 63:2107\u20132126","journal-title":"Drugs"},{"key":"6337_CR21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1651-2227.1991.tb11782.x","volume":"80","author":"T Vesikari","year":"1991","unstructured":"Vesikari T, Ohrling A, Baer M, Delem A, Bogaerts H, Andre FE (1991) Evaluation of live attenuated varicella vaccine (Oka-RIT strain) and combined varicella and MMR vaccination in 13\u201317 month-old children. Acta Paediatr Scand 80:1051\u20131057","journal-title":"Acta Paediatr Scand"},{"key":"6337_CR22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/infdis\/173.3.731","volume":"173","author":"BM Watson","year":"1996","unstructured":"Watson BM, Laufer DS, Kuter BJ, Staehle B, White CJ, Starr SE (1996) Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children. J Infect Dis 173:731\u2013734","journal-title":"J Infect Dis"},{"key":"6337_CR23","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/clinids\/24.5.925","volume":"24","author":"CJ White","year":"1997","unstructured":"White CJ, Stinson D, Staehle B, Cho I, Matthews H, Ngai A, Keller P, Eiden J, Kuter B (1997) Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, mumps, rubella, varicella vaccine study group. Clin Infect Dis 24:925\u2013931","journal-title":"Clin Infect Dis"},{"key":"6337_CR24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0264-410X(02)00459-0","volume":"21","author":"T Nolan","year":"2002","unstructured":"Nolan T, McIntyre P, Roberton D, Descamps D (2002) Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine. Vaccine 21:281\u2013289","journal-title":"Vaccine"},{"key":"6337_CR25","unstructured":"Vesikari T, Baer M, Vandevoorde D: An early dose-finding study for an experimental MMRV vaccine (Abstract). In: 4th World Congress of The World Society of Paediatric Infectious Diseases, Warsaw, Poland 2005"},{"key":"6337_CR26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","volume":"24","author":"H Shinefield","year":"2005","unstructured":"Shinefield H, Black S, Digilio L, Reisinger K, Blatter M, Gress JO, Brown ML, Eves KA, Klopfer SO, Schodel F, Kuter BJ (2005) Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatr Infect Dis J 24:665\u2013669","journal-title":"Pediatr Infect Dis J"},{"key":"6337_CR27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.inf.0000195626.35239.58","volume":"25","author":"M Knuf","year":"2006","unstructured":"Knuf M, Habermehl P, Zepp F, Mannhardt W, Kuttnig M, Muttonen P, Prieler A, Maurer H, Bisanz H, Tornieporth N, Descamps D, Willems P (2006) Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children. Pediatr Infect Dis J 25:12\u201318","journal-title":"Pediatr Infect Dis J"},{"key":"6337_CR28","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(86)91044-5","volume":"1","author":"H Peltola","year":"1986","unstructured":"Peltola H, Heinonen OP (1986) Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet 1:939\u2013942","journal-title":"Lancet"},{"key":"6337_CR29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0264-410X(91)90053-9","volume":"9","author":"RT Chen","year":"1991","unstructured":"Chen RT, Moses JM, Markowitz LE, Orenstein WA (1991) Adverse events following measles-mumps-rubella and measles vaccinations in college students. Vaccine 9:297\u2013299","journal-title":"Vaccine"},{"key":"6337_CR30","unstructured":"Centers for Disease Control and Prevention: Measles. In: Atkinson W, Hamborsky J, McIntyre L, Wolfe S (eds.) Epidemiology and prevention of vaccine-preventable diseases (9th edn). Public Health Foundation, Washington DC 2006, pp 125\u2013144"},{"key":"6337_CR31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00006454-199901000-00011","volume":"18","author":"V Usonis","year":"1999","unstructured":"Usonis V, Bakasenas V, Kaufhold A, Chitour K, Clemens R (1999) Reactogenicity of a new live attenuated combined measles, mumps, rubella vaccine in healthy children. Pediatr Infect Dis J 18:42\u201348","journal-title":"Pediatr Infect Dis J"},{"key":"6337_CR32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.280.6.527","volume":"280","author":"HA Gans","year":"1998","unstructured":"Gans HA, Arvin AM, Galinus J, Logan L, DeHovitz R, Maldonado Y (1998) Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 280:527\u2013532","journal-title":"JAMA"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-007-6337-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-007-6337-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-007-6337-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-007-6337-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T12:04:09Z","timestamp":1659096249000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-007-6337-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,20]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["6337"],"URL":"https:\/\/doi.org\/10.1007\/s15010-007-6337-z","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,20]]},"assertion":[{"value":"21 November 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}